Search

Showing "11155" results for ""

Condoms reduce genital herpes risk for both men and women

Previous immune damage and response to HIV treatment associated with TB after starting antiretrovirals

HIV treatment reduces risk of TB in South Africa more than previously thought

Higher doses of pegylated interferon or ribavirin improve hepatitis C treatment response rates

Non-invasive markers of liver damage effective in HIV / hepatitis C co-infected patients

Less than half of deaths at London HIV clinic due to AIDS since 1998

Microbicide gel can prevent HIV and herpes infection of human cells

Neurological side-effects of efavirenz mild and transient, study claims

HIV-positive injecting drug users who are infected with HTLV-II less are less likely to progress to AIDS

Premature to say atazanavir not linked to fat loss, says lipodystrophy expert

Clostridium difficile most common cause of bacterial diarrhoea in HIV-positive patients

HAART reduces liver damage in HIV / hepatitis C co-infected patients

Primary drug resistance has limited effect on disease progression and response to treatment

Advocacy groups demand equal HIV treatment access for injecting drug users

Limb fat gains lower when switching from AZT to abacavir or tenofovir, compared with d4T

New study looks at impact of AIDS on South Africa

ICAAC: No added benefit from adding AZT to nevirapine to prevent MTCT

UK Government to be sued over lack of PEP policy for sexual exposure to HIV

Receive the latest HIV research and conference news

Showing "11155" results for ""

Condoms reduce genital herpes risk for both men and women

Previous immune damage and response to HIV treatment associated with TB after starting antiretrovirals

HIV treatment reduces risk of TB in South Africa more than previously thought

Higher doses of pegylated interferon or ribavirin improve hepatitis C treatment response rates

Non-invasive markers of liver damage effective in HIV / hepatitis C co-infected patients

Less than half of deaths at London HIV clinic due to AIDS since 1998

Microbicide gel can prevent HIV and herpes infection of human cells

Neurological side-effects of efavirenz mild and transient, study claims

HIV-positive injecting drug users who are infected with HTLV-II less are less likely to progress to AIDS

Premature to say atazanavir not linked to fat loss, says lipodystrophy expert

Clostridium difficile most common cause of bacterial diarrhoea in HIV-positive patients

HAART reduces liver damage in HIV / hepatitis C co-infected patients

Primary drug resistance has limited effect on disease progression and response to treatment

Advocacy groups demand equal HIV treatment access for injecting drug users

Limb fat gains lower when switching from AZT to abacavir or tenofovir, compared with d4T

New study looks at impact of AIDS on South Africa

ICAAC: No added benefit from adding AZT to nevirapine to prevent MTCT

UK Government to be sued over lack of PEP policy for sexual exposure to HIV

Receive the latest HIV research and conference news